Viewing Study NCT06192004



Ignite Creation Date: 2024-05-06 @ 7:57 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06192004
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2023-11-28

Brief Title: Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of PneumonitisILD
Sponsor: AstraZeneca
Organization: AstraZeneca

Study Overview

Official Title: An Observational Prospective Multicenter Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of PneumonitisILD
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: LOOP
Brief Summary: This is an observational prospective multicenter study conducted in the US to gather evidence in the context of lung cancer to complement the development of a digital solution

Patients initiating treatment for non-small cell lung cancer NSCLC will be prospectively followed to characterize risk factors signs and symptoms leading to onset diagnosis and treatment of pneumonitisILD should it occur
Detailed Description: This is an observational prospective multicenter study conducted in the US to gather evidence in the context of lung cancer to complement the development of a digital solution

Data will be collected prospectively from study sites using eCRFs and remotely from patients using a digital health tool

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None